NCT01643603 2020-12-17
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
Barbara Ann Karmanos Cancer Institute
Phase 1 Terminated
Barbara Ann Karmanos Cancer Institute
Indiana University
Exelixis
H. Lee Moffitt Cancer Center and Research Institute
Radboud University Medical Center